ArticleBMC cancer2024

Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.

Xiuli Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.